小摩增持恒瑞医药约112.78万股 每股作价约74.61港元

Group 1 - The core point of the article is that JPMorgan has increased its stake in Heng Rui Medicine (600276) by purchasing 112,782.8 shares at a price of 74.6126 HKD per share, totaling approximately 84.15 million HKD [1] - After the purchase, JPMorgan's total holdings in Heng Rui Medicine amount to approximately 19.194 million shares, representing a holding percentage of 7.43% [1]